Literature DB >> 10711336

Acellular dermal allograft for sellar reconstruction after transsphenoidal hypophysectomy.

M J Citardi1, A J Cox, R D Bucholz.   

Abstract

Obliteration of the sphenoid sinus using fat is often used after transsphenoidal hypophysectomy. The morbidity of this approach includes donor site complications, fat necrosis, and delayed mucocele formation. As obliteration with fat is intended to prevent cerebrospinal fluid (CSF) leakage, an alternative for this technique would be techniques used for CSF rhinorrhea repair. Instead of sinus obliteration, these defects are repaired with fascial autografts, which are unfortunately associated with donor site complications. To avoid sinus obliteration and donor site complications, we have reconstructed the sella with acellular dermal allograft in lieu of sinus obliteration. Transsphenoidal hypophysectomy was performed under combined microscopic and endoscopic visualization. For closure, the sellar anterior wall was reconstructed with acellular dermal allograft, septal cartilage/bone autograft, and fibrin glue. The sinus mucosa was then draped over the reconstruction and held in place with microfibrillar collagen hemostat slurry. The sphenoid sinus was not obliterated. Postoperatively, all patients underwent serial nasal endoscopy. Thirteen patients underwent the procedure as described for removal of pituitary adenoma. Postoperative discomfort and pain were minimal. Intraoperative CSF leaks were identified in five patients; none of these patients experienced a postoperative CSF leak. The microfibrillar collagen hemostat was cleared by sphenoid mucociliary clearance. One patient developed acute sphenoid sinusitis several weeks after surgery; this patient did not develop meningitis. One postoperative CSF leak occurred in an obese patient, in whom an intraoperative CSF leak was not identified; this leak resolved with bedrest and delayed lumbar drainage alone. Sellar reconstruction with acellular dermal allograft may eliminate the need for sphenoid sinus obliteration after transsphenoidal hypophysectomy. Acellular dermal allograft sellar reconstruction ultimately provides for an aerated, functioning sphenoid sinus without increased CSF leak risk or potential donor site morbidity.

Entities:  

Mesh:

Year:  2000        PMID: 10711336     DOI: 10.2500/105065800781602920

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  6 in total

1.  Endoscopic pedicled nasoseptal flap repair of spontaneous sphenoid sinus cerebrospinal fluid leaks.

Authors:  Dakshika Abeydeera Gunaratne; Narinder Pal Singh
Journal:  BMJ Case Rep       Date:  2015-04-29

2.  Fibrin-coated collagen fleece versus absorbable dural sealant for sellar closure after transsphenoidal pituitary surgery: a comparative study.

Authors:  Justin Moore; Nathalie Zaidman; Isabel Fernandes Arroteia; Geoffrey Appelboom; Sami Barrit; Sébastien Carlot; Viviane De Maertelaer; Sergio Hassid; Olivier De Witte; Julien Spitaels
Journal:  Sci Rep       Date:  2022-05-14       Impact factor: 4.996

3.  Acellular dermal allograft for sellar repair after transsphenoidal approach to pituitary adenomas.

Authors:  Brandon G Gaynor; Ronald J Benveniste; Seth Lieberman; Roy Casiano; Jacques J Morcos
Journal:  J Neurol Surg B Skull Base       Date:  2013-03-13

4.  One-piece modified gasket seal technique.

Authors:  Aaron Wessell; Ameet Singh; Zachary Litvack
Journal:  J Neurol Surg B Skull Base       Date:  2013-06-13

5.  An Algorithm for Sellar Reconstruction Following the Endoscopic Endonasal Approach: A Review of 300 Consecutive Cases.

Authors:  Edward C Kuan; Frederick Yoo; Pratik B Patel; Brooke M Su; Marvin Bergsneider; Marilene B Wang
Journal:  J Neurol Surg B Skull Base       Date:  2017-08-28

6.  Skull base repair following endonasal pituitary and skull base tumour resection: a systematic review.

Authors:  Danyal Z Khan; Ahmad M S Ali; Chan Hee Koh; Neil L Dorward; Joan Grieve; Hugo Layard Horsfall; William Muirhead; Thomas Santarius; Wouter R Van Furth; Amir H Zamanipoor Najafabadi; Hani J Marcus
Journal:  Pituitary       Date:  2021-05-10       Impact factor: 4.107

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.